Company Data
Kalaris Therapeutics Inc.
Ticker
KLRS
Current Price
$2.82 -2.76%
Market Cap
$52.7M
Price Target
Refer to Report
Volume
9.2K
52wk Range
$2.645 - $24.15
Overview
Kalaris was founded by experienced leaders in ophthalmology drug development and commercialization to address a major unmet need in the treatment of retinal diseases.Existing therapies for retinal neovascular / exudative diseases have made great strides in preserving or improving vision, but they require frequent clinic visits over many years that place a significant burden on patients and caregivers. This onerous visit regimen often leads to missed or delayed injections and suboptimal patient outcomes.